Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160537
Status:
COMPLETED
Last Update Posted:
2013-12-16
First Post:
2005-09-08
Brief Title:
POPULAR Preference Of Patient Using Levocetirizine in Allergic Rhinitis
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Study Overview
Official Title:
A Monocenter Double-blind Randomized Trial With Two Parallel Groups Comparing the Clinical Efficacy of Levocetirizine 5 mg Capsules and Desloratadine 5 mg Capsules Taken Once a Day Over 3 Weeks of Treatment in Adult Subjects Suffering From Seasonal Allergic Rhinitis SAR Due to Grass Pollen
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subjects satisfactiondissatisfaction after one week of treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| POPULAR | None | None | None |
| EudraCT 2004-002971-18 | None | None | None |